Safety Study of JADE101 in Healthy Japanese and Chinese Adults
This is an early-stage safety study of an experimental medicine called JADE101. Researchers want to give a single dose to healthy volunteers of Japanese or Chinese heritage to see how the body handles it and watch for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old and in good health
- Be of first-generation Japanese or Chinese descent, born in Japan or China
- Weigh between 40 and 100 kg (88–220 pounds) with a healthy BMI (roughly 18–32)
- Not smoke, vape, or use tobacco heavily in the past 2 years
- Not abuse alcohol or illicit drugs
- Not be pregnant, nursing, or planning to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
This study tests a new drug called AZD4916 in healthy people to see if it's safe and how the body processes it. It may help decide if the drug is safe enough for future studies.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This study tests how food affects how the body absorbs and processes a new experimental drug called AJ201. Researchers will give the drug to healthy men with and without food to see if it makes a difference, and they'll check for any side effects.
This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.